November 14, 2012 / 6:18 AM / 5 years ago

Celesio posts unexpected Q3 loss on impairments

FRANKFURT, Nov 14 (Reuters) - Celesio, Europe’s largest drugs distributor, swung to an unexpected third-quarter net loss of 6.6 million euros ($8.39 million) on impairment charges taken at units it is selling.

The net loss compares with a net income of 38.1 million euros expected on average by analysts in a Reuters poll and with a year-earlier net profit of 59.9 million.

$1 = 0.7867 euros Reporting by Ludwig Burger

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below